137 related articles for article (PubMed ID: 36292206)
1. Analysis of More than 16,000 Human Tumor and Normal Tissues Identifies Uroplakin 3B as a Useful Diagnostic Marker for Mesothelioma and Normal Mesothelial Cells.
Lennartz M; Atug D; Dwertmann Rico S; Reiswich V; Viehweger F; Büscheck F; Kluth M; Hube-Magg C; Hinsch A; Bernreuther C; Sauter G; Burandt E; Marx AH; Krech T; Simon R; Minner S; Clauditz TS; Jacobsen F; Lebok P; Gorbokon N; Möller K; Steurer S; Fraune C
Diagnostics (Basel); 2022 Oct; 12(10):. PubMed ID: 36292206
[TBL] [Abstract][Full Text] [Related]
2. Large-scale human tissue analysis identifies Uroplakin 1a as a putative diagnostic marker for urothelial cancer.
Reiswich V; Könemann S; Lennartz M; Höflmayer D; Menz A; Chirico V; Hube-Magg C; Fraune C; Bernreuther C; Simon R; Clauditz TS; Sauter G; Hinsch A; Kind S; Jacobsen F; Steurer S; Minner S; Büscheck F; Burandt E; Marx AH; Lebok P; Krech T
Pathol Res Pract; 2022 Sep; 237():154028. PubMed ID: 35872365
[TBL] [Abstract][Full Text] [Related]
3. LRRN4 and UPK3B are markers of primary mesothelial cells.
Kanamori-Katayama M; Kaiho A; Ishizu Y; Okamura-Oho Y; Hino O; Abe M; Kishimoto T; Sekihara H; Nakamura Y; Suzuki H; Forrest AR; Hayashizaki Y
PLoS One; 2011; 6(10):e25391. PubMed ID: 21984916
[TBL] [Abstract][Full Text] [Related]
4. Loss of Upk1a and Upk1b expression is linked to stage progression in urothelial carcinoma of the bladder.
Kaczmarek K; Plage H; Furlano K; Hofbauer S; Weinberger S; Ralla B; Franz A; Fendler A; de Martino M; Roßner F; Schallenberg S; Elezkurtaj S; Kluth M; Lennartz M; Blessin NC; Marx AH; Samtleben H; Fisch M; Rink M; Slojewski M; Ecke T; Hallmann S; Koch S; Adamini N; Minner S; Simon R; Sauter G; Weischenfeldt J; Klatte T; Schlomm T; Horst D; Zecha H
Int Urol Nephrol; 2024 Feb; 56(2):499-508. PubMed ID: 37777995
[TBL] [Abstract][Full Text] [Related]
5. Large-scale human tissue analysis identifies Uroplakin 1b as a putative diagnostic marker in surgical pathology.
Reiswich V; Akdeniz G; Lennartz M; Menz A; Chirico V; Hube-Magg C; Fraune C; Bernreuther C; Simon R; Clauditz TS; Sauter G; Uhlig R; Hinsch A; Kind S; Jacobsen F; Möller K; Steurer S; Minner S; Burandt E; Marx AH; Lebok P; Krech T; Dum D
Hum Pathol; 2022 Aug; 126():108-120. PubMed ID: 35550834
[TBL] [Abstract][Full Text] [Related]
6. Spatiotemporal expression of UPK3B and its promoter activity during embryogenesis and spermatogenesis.
Kuriyama S; Tamiya Y; Tanaka M
Histochem Cell Biol; 2017 Jan; 147(1):17-26. PubMed ID: 27577269
[TBL] [Abstract][Full Text] [Related]
7. Frequency of Androgen Receptor Positivity in Tumors: A Study Evaluating More Than 18,000 Tumors.
Viehweger F; Hoop J; Tinger LM; Bernreuther C; Büscheck F; Clauditz TS; Hinsch A; Jacobsen F; Luebke AM; Steurer S; Hube-Magg C; Kluth M; Marx AH; Krech T; Lebok P; Fraune C; Burandt E; Sauter G; Simon R; Minner S
Biomedicines; 2024 Apr; 12(5):. PubMed ID: 38790919
[TBL] [Abstract][Full Text] [Related]
8. Potential utility of uroplakin III, thrombomodulin, high molecular weight cytokeratin, and cytokeratin 20 in noninvasive, invasive, and metastatic urothelial (transitional cell) carcinomas.
Parker DC; Folpe AL; Bell J; Oliva E; Young RH; Cohen C; Amin MB
Am J Surg Pathol; 2003 Jan; 27(1):1-10. PubMed ID: 12502922
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic and prognostic impact of cytokeratin 18 expression in human tumors: a tissue microarray study on 11,952 tumors.
Menz A; Weitbrecht T; Gorbokon N; Büscheck F; Luebke AM; Kluth M; Hube-Magg C; Hinsch A; Höflmayer D; Weidemann S; Fraune C; Möller K; Bernreuther C; Lebok P; Clauditz T; Sauter G; Uhlig R; Wilczak W; Steurer S; Minner S; Burandt E; Krech R; Dum D; Krech T; Marx A; Simon R
Mol Med; 2021 Feb; 27(1):16. PubMed ID: 33588765
[TBL] [Abstract][Full Text] [Related]
10. Brenner tumors but not transitional cell carcinomas of the ovary show urothelial differentiation: immunohistochemical staining of urothelial markers, including cytokeratins and uroplakins.
Riedel I; Czernobilsky B; Lifschitz-Mercer B; Roth LM; Wu XR; Sun TT; Moll R
Virchows Arch; 2001 Feb; 438(2):181-91. PubMed ID: 11253121
[TBL] [Abstract][Full Text] [Related]
11. Expression of carbonic anhydrase IX (CAIX) in malignant mesothelioma. An immunohistochemical and immunocytochemical study.
Capkova L; Koubkova L; Kodet R
Neoplasma; 2014; 61(2):161-9. PubMed ID: 24471939
[TBL] [Abstract][Full Text] [Related]
12. Cytokeratin 5 and cytokeratin 6 expressions are unconnected in normal and cancerous tissues and have separate diagnostic implications.
Völkel C; De Wispelaere N; Weidemann S; Gorbokon N; Lennartz M; Luebke AM; Hube-Magg C; Kluth M; Fraune C; Möller K; Bernreuther C; Lebok P; Clauditz TS; Jacobsen F; Sauter G; Uhlig R; Wilczak W; Steurer S; Minner S; Krech RH; Dum D; Krech T; Marx AH; Simon R; Burandt E; Menz A
Virchows Arch; 2022 Feb; 480(2):433-447. PubMed ID: 34559291
[TBL] [Abstract][Full Text] [Related]
13. Sarcomatoid mesothelioma and its histological mimics: a comparative immunohistochemical study.
Lucas DR; Pass HI; Madan SK; Adsay NV; Wali A; Tabaczka P; Lonardo F
Histopathology; 2003 Mar; 42(3):270-9. PubMed ID: 12605647
[TBL] [Abstract][Full Text] [Related]
14. Value of mesothelin immunostaining in the diagnosis of mesothelioma.
Ordóñez NG
Mod Pathol; 2003 Mar; 16(3):192-7. PubMed ID: 12640097
[TBL] [Abstract][Full Text] [Related]
15. p63 expression in human tumors and normal tissues: a tissue microarray study on 10,200 tumors.
Steurer S; Riemann C; Büscheck F; Luebke AM; Kluth M; Hube-Magg C; Hinsch A; Höflmayer D; Weidemann S; Fraune C; Möller K; Menz A; Fisch M; Rink M; Bernreuther C; Lebok P; Clauditz TS; Sauter G; Uhlig R; Wilczak W; Dum D; Simon R; Minner S; Burandt E; Krech R; Krech T; Marx AH
Biomark Res; 2021 Jan; 9(1):7. PubMed ID: 33494829
[TBL] [Abstract][Full Text] [Related]
16. Urothelial umbrella cells of human ureter are heterogeneous with respect to their uroplakin composition: different degrees of urothelial maturity in ureter and bladder?
Riedel I; Liang FX; Deng FM; Tu L; Kreibich G; Wu XR; Sun TT; Hergt M; Moll R
Eur J Cell Biol; 2005 Mar; 84(2-3):393-405. PubMed ID: 15819416
[TBL] [Abstract][Full Text] [Related]
17. PAX8 reliably distinguishes ovarian serous tumors from malignant mesothelioma.
Laury AR; Hornick JL; Perets R; Krane JF; Corson J; Drapkin R; Hirsch MS
Am J Surg Pathol; 2010 May; 34(5):627-35. PubMed ID: 20414098
[TBL] [Abstract][Full Text] [Related]
18. Uroplakin III is a highly specific and moderately sensitive immunohistochemical marker for primary and metastatic urothelial carcinomas.
Kaufmann O; Volmerig J; Dietel M
Am J Clin Pathol; 2000 May; 113(5):683-7. PubMed ID: 10800401
[TBL] [Abstract][Full Text] [Related]
19. The "Brescia panel" (Claudin-4 and BRCA-associated protein 1) in the differential diagnosis of mesotheliomas with epithelioid features versus metastatic carcinomas.
Bernardi L; Bizzarro T; Pironi F; Szymczuk S; Buda R; Fabbri E; Di Claudio G; Rossi G
Cancer Cytopathol; 2021 Apr; 129(4):275-282. PubMed ID: 33045147
[TBL] [Abstract][Full Text] [Related]
20. Upk3b is dispensable for development and integrity of urothelium and mesothelium.
Rudat C; Grieskamp T; Röhr C; Airik R; Wrede C; Hegermann J; Herrmann BG; Schuster-Gossler K; Kispert A
PLoS One; 2014; 9(11):e112112. PubMed ID: 25389758
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
